Peripheral blood CADM1 expression and multi-gene signatures in depressive disorders: a pilot case-control study from the United Arab Emirates - Report - MDSpire
Advertisement
Peripheral blood CADM1 expression and multi-gene signatures in depressive disorders: a pilot case-control study from the United Arab Emirates
Clinical Report: Expression of CADM1 and Multi-Gene Profiles in Depression
Overview
This pilot study investigates the expression of CADM1 and other genes in peripheral blood among individuals with depressive disorders in the UAE.
Background
Depressive disorders are a leading cause of disability worldwide, yet research on gene expression in Middle Eastern populations is limited. This study examines gene expression profiles in a UAE cohort.
Data Highlights
No significant diagnostic utility was found for CADM1, with an area under the curve of 0.616.
Key Findings
CADM1 expression was modestly upregulated in individuals with depressive disorders (1.30-fold increase).
Principal component analysis indicated a significant difference driven by CADM1 and RAPH1.
CADM1 correlated negatively with depression severity (BDI-II ρ = −0.280, p = 0.005).
Age balancing eliminated the CADM1 effect, suggesting confounding factors.
Exploratory analyses indicated potential sex-specific patterns in gene expression.
Clinical Implications
The findings indicate the limitations of CADM1 as a potential biomarker for depression due to the small sample size and confounding factors present in this study.
Conclusion
This pilot study provides insights into gene expression in depression among a UAE population.
Integrated proteomic and metabolomic analyses identified redox-metabolic signatures associated with chronic posttraumatic stress disorder and accelerated biological aging across multiple organ systems.
